Vera-Badillo, et al. conducted a systemic review of 19 studies that assessed AR immunohistochemistry (IHC) in 7693 patients with early stage breast cancer and found AR staining present in 60.5% of patients; interestingly, AR positivity was associated with improved overall survival (OS) [57]. The gene discussed is AR; the disease is breast cancer.